Discover 176 paid clinical trials in Maine. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maine offers nearby opportunities for both healthy volunteers seeking paid studies and individuals with specific health conditions to participate in valuable research. Major research centers in Portland, Bangor, and Augusta are actively recruiting, providing easy access to advanced medical care and new treatment options.
Filter
1
Filter results
Results: 176
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Location: Brunswick ME, Portland ME, Boston MA, Philadelphia PA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT07150923
Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Westbrook ME, Lebanon NH, Summit NJ, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase 3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Location: Bangor ME, Boston MA, Providence RI, Manchester NH,
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 2
Code: NCT07243652
Recruiting
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for
Neovascular Age-related Macular Degeneration
Location: Portland ME, Little Silver NJ, Philadelphia PA,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07007065
Phase 3, Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, Fall River MA, Quebec, North Massapequa NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT07177339
Phase 3, Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Westbrook ME, Burlington MA, New York NY,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase 3, Recruiting
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
for
Asthma
Location: Bangor ME, Glenn Dale MD, Ellicott City MD,
Sponsor: Biometry Inc
Sex: All
Age: 5 - 70+
Code: NCT07228026
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Brewer ME, Rockport ME, Brunswick ME, South Portland ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase 3, Recruiting
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer